CimCure
An Amsterdam UMC-based biotech spin-off, which focuses on developing vaccine-based cancer immunotherapy
Amsterdam, Netherlandscimcure.com ↗
Total raised
€5.0M
€5,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2022-06
latest 2022-06
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood16
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-06-07 | Seed | €5.0M | Positron Ventures,Tom Würdinger | View deal → |
Investors
2Related news
- Dutch cancer vaccine biotech CimCure fetches €5M to shrink a tumor effectivelytechfundingnews.com · 2022-06
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- Roivant Sciences€1.2BSwitzerland · Healthtech